drugset / Trial / NCT04858490

Summary

This study will evaluate the feasibility of delivering symptom-triggered alcohol withdrawal management by telemedicine and determine whether this intervention is satisfactory to patients.

Timeline

Start
2021-09-24
Primary completion
2023-10-16
Completion
2023-11-21

Drugs

EvaluationDrugModalityDoseRoute
Subject Diazepam Small molecule 10 mg
Subject Diazepam Small molecule 20 mg

Indications